Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans
Conclusions. These data support further clinical development of this candidate vaccine. Our approach helps fill the gap in clinical tuberculosis vaccine development.
Source: The Journal of Infectious Diseases - Category: Infectious Diseases Authors: Jeyanathan, M., Damjanovic, D., Yao, Y., Bramson, J., Smaill, F., Xing, Z. Tags: BACTERIA Source Type: research
More News: Adenoviruses | Allergy & Immunology | Clinical Trials | Genetics | Infectious Diseases | Tuberculosis | Tuberculosis (BCG) Vaccine | Vaccines